Design of phase II non-inferiority trials

With the development of inexpensive treatment regimens and less invasive surgical procedures, we are confronted with non-inferiority study objectives. A non-inferiority phase III trial requires a roughly four times larger sample size than that of a similar standard superiority trial. Because of the...

Full description

Bibliographic Details
Main Author: Sin-Ho Jung
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:Contemporary Clinical Trials Communications
Online Access:http://www.sciencedirect.com/science/article/pii/S245186541630134X
id doaj-90e8fc3f7c1645a9b51efaf22c02eff4
record_format Article
spelling doaj-90e8fc3f7c1645a9b51efaf22c02eff42020-11-24T20:57:08ZengElsevierContemporary Clinical Trials Communications2451-86542017-09-0172327Design of phase II non-inferiority trialsSin-Ho Jung0Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USAWith the development of inexpensive treatment regimens and less invasive surgical procedures, we are confronted with non-inferiority study objectives. A non-inferiority phase III trial requires a roughly four times larger sample size than that of a similar standard superiority trial. Because of the large required sample size, we often face feasibility issues to open a non-inferiority trial. Furthermore, due to lack of phase II non-inferiority trial design methods, we do not have an opportunity to investigate the efficacy of the experimental therapy through a phase II trial. As a result, we often fail to open a non-inferiority phase III trial and a large number of non-inferiority clinical questions still remain unanswered. In this paper, we want to develop some designs for non-inferiority randomized phase II trials with feasible sample sizes. At first, we review a design method for non-inferiority phase III trials. Subsequently, we propose three different designs for non-inferiority phase II trials that can be used under different settings. Each method is demonstrated with examples. Each of the proposed design methods is shown to require a reasonable sample size for non-inferiority phase II trials. The three different non-inferiority phase II trial designs are used under different settings, but require similar sample sizes that are typical for phase II trials. Keywords: Binary outcome, Non-inferiority margin, Phase II/III trials, Randomized phase II trials, Sample size calculation, Survival outcomehttp://www.sciencedirect.com/science/article/pii/S245186541630134X
collection DOAJ
language English
format Article
sources DOAJ
author Sin-Ho Jung
spellingShingle Sin-Ho Jung
Design of phase II non-inferiority trials
Contemporary Clinical Trials Communications
author_facet Sin-Ho Jung
author_sort Sin-Ho Jung
title Design of phase II non-inferiority trials
title_short Design of phase II non-inferiority trials
title_full Design of phase II non-inferiority trials
title_fullStr Design of phase II non-inferiority trials
title_full_unstemmed Design of phase II non-inferiority trials
title_sort design of phase ii non-inferiority trials
publisher Elsevier
series Contemporary Clinical Trials Communications
issn 2451-8654
publishDate 2017-09-01
description With the development of inexpensive treatment regimens and less invasive surgical procedures, we are confronted with non-inferiority study objectives. A non-inferiority phase III trial requires a roughly four times larger sample size than that of a similar standard superiority trial. Because of the large required sample size, we often face feasibility issues to open a non-inferiority trial. Furthermore, due to lack of phase II non-inferiority trial design methods, we do not have an opportunity to investigate the efficacy of the experimental therapy through a phase II trial. As a result, we often fail to open a non-inferiority phase III trial and a large number of non-inferiority clinical questions still remain unanswered. In this paper, we want to develop some designs for non-inferiority randomized phase II trials with feasible sample sizes. At first, we review a design method for non-inferiority phase III trials. Subsequently, we propose three different designs for non-inferiority phase II trials that can be used under different settings. Each method is demonstrated with examples. Each of the proposed design methods is shown to require a reasonable sample size for non-inferiority phase II trials. The three different non-inferiority phase II trial designs are used under different settings, but require similar sample sizes that are typical for phase II trials. Keywords: Binary outcome, Non-inferiority margin, Phase II/III trials, Randomized phase II trials, Sample size calculation, Survival outcome
url http://www.sciencedirect.com/science/article/pii/S245186541630134X
work_keys_str_mv AT sinhojung designofphaseiinoninferioritytrials
_version_ 1716788737039400960